MedPath

University of Pennsylvania

University of Pennsylvania logo
🇺🇸United States
Ownership
Private
Established
1740-11-14
Employees
5K
Market Cap
-
Website
http://www.upenn.edu

Partial Reinforcement II: Three Approaches to Maintenance Therapy for Chronic Insomnia

Phase 4
Completed
Conditions
Insomnia
Insomnia Chronic
Interventions
First Posted Date
2018-12-13
Last Posted Date
2024-07-22
Lead Sponsor
University of Pennsylvania
Target Recruit Count
198
Registration Number
NCT03774810
Locations
🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

Remote Observed Dosing of Suboxone to Improve Clinical Practice

Phase 1
Completed
Conditions
Opioid-use Disorder
Opioid Dependence
Opiate Dependence
Interventions
Behavioral: Suboxone Remote Observed Dosing
Other: Suboxone Attention Control
First Posted Date
2018-12-07
Last Posted Date
2023-07-27
Lead Sponsor
University of Pennsylvania
Target Recruit Count
16
Registration Number
NCT03769025
Locations
🇺🇸

University of Pennsylvania Treatment Research Center, Philadelphia, Pennsylvania, United States

Lentivirally Redirected CD123 Autologous T Cells in AML

Phase 1
Active, not recruiting
Conditions
Acute Myeloid Leukemia, Adult
Acute Myeloid Leukemia, Refractory
Acute Myeloid Leukemia, in Relapse
Interventions
Biological: CART123 cells; cyclophosphamide; fludarabine
First Posted Date
2018-12-06
Last Posted Date
2024-08-06
Lead Sponsor
University of Pennsylvania
Target Recruit Count
22
Registration Number
NCT03766126
Locations
🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

Oritavancin for Staphylococcus Aureus Infections in Opioid Users

Phase 4
Withdrawn
Conditions
Staphylococcus Aureus Endocarditis
Staphylococcus Aureus Bacteremia
Interventions
First Posted Date
2018-12-03
Last Posted Date
2022-04-06
Lead Sponsor
University of Pennsylvania
Registration Number
NCT03761953
Locations
🇺🇸

Clinical Trials Unit. University of Pennsylvania, Philadelphia, Pennsylvania, United States

Imiquimod for Preventing Keloid Recurrence

Phase 2
Terminated
Conditions
Keloid
Interventions
First Posted Date
2018-11-30
Last Posted Date
2020-11-19
Lead Sponsor
University of Pennsylvania
Target Recruit Count
6
Registration Number
NCT03760250
Locations
🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

Evaluation of the Novel Use of Gamification With Alternative Goal-setting Experiences

Not Applicable
Completed
Conditions
Atherosclerotic Cardiovascular Disease
Interventions
Behavioral: Daily performance feedback
Behavioral: Choice + Immediate
Behavioral: Assigned + Gradual
Behavioral: Choice + Gradual
Behavioral: Assigned + Immediate
Behavioral: Gamification
First Posted Date
2018-11-21
Last Posted Date
2020-06-04
Lead Sponsor
University of Pennsylvania
Target Recruit Count
500
Registration Number
NCT03749473
Locations
🇺🇸

Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, United States

PET Imaging in Patients With Suspected Cardiac Sarcoidosis

Completed
Conditions
Cardiac Sarcoidosis
Interventions
First Posted Date
2018-11-20
Last Posted Date
2022-12-14
Lead Sponsor
University of Pennsylvania
Target Recruit Count
20
Registration Number
NCT03746847
Locations
🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

Incentivizing Planning & Output in Exercising

Not Applicable
Completed
Conditions
Healthy
Interventions
Behavioral: Incentivizing planning
Behavioral: Incentivizing exercise
First Posted Date
2018-11-15
Last Posted Date
2020-06-11
Lead Sponsor
University of Pennsylvania
Target Recruit Count
1200
Registration Number
NCT03742765
Locations
🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

Incentivizing Reflection and Output in Exercise

Not Applicable
Completed
Conditions
Healthy
Interventions
Behavioral: Incentivizing reflection
Behavioral: Incentivizing exercise
First Posted Date
2018-11-15
Last Posted Date
2020-06-11
Lead Sponsor
University of Pennsylvania
Target Recruit Count
1200
Registration Number
NCT03742778
Locations
🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

Low-Level Laser in Treatment of Head and Neck Lymphedema: A Pilot Study

Not Applicable
Completed
Conditions
Fibrosis
Head and Neck Cancer
Lymphedema
Interventions
Device: Low-Level Laser
First Posted Date
2018-11-13
Last Posted Date
2022-02-01
Lead Sponsor
University of Pennsylvania
Target Recruit Count
12
Registration Number
NCT03738332
Locations
🇺🇸

University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath